COVID-19 TREATMENT RESEARCH | @CovidAnalysis | C19IVM.ORG | MARCH 9, 2024
PHOTO CREDIT | JAIZ ANUAR/ISTOCK/GETTY IMAGES PLUS
HIGHLIGHTS
Ivermectin reduces risk for COVID-19 with very high confidence for mortality, ventilation, hospitalization, progression, recovery, cases, viral clearance, and in pooled analysis, and high confidence for ICU admission.
4th treatment shown effective with ?3 clinical studies in August 2020, now with p < 0.00000000001 from 101 studies, and recognized in 22 countries.
We show outcome specific analyses and combined evidence from all studies, incorporating treatment delay, a primary confounding factor for COVID-19.
Real-time updates and corrections, transparent analysis with all results in the same format, consistent protocol for 66 treatments.
LINK TO IVERMECTIN FOR COVID-19: REAL-TIME META ANALYSIS OF 101 STUDIES
(easier to read)
Downloadable PDF from the KBSOS archive of ‘Ivermectin for COVID-19: Real-Time Meta Analysis of 101 Studies’
Last Updated on March 26, 2024 by Real KBrett